Table 1.
Clinical and biochemical parameters in all diabetic patients and healthy control.
| Parameter | All patients withDM1 | n | Controls | N |
|---|---|---|---|---|
| Age (r.) | 15.2 ± 2.7 | 79 | 9.2 ± 4.9 | 31 |
| Duration of DM (r.) | 8.7 ± 3.0 | 79 | — | — |
| UAER (μg/min) | 37.8 ± 116.8 | 74 | — | — |
| FAM (mmol/L) | 2.85 ± 0.50 | 75 | 1.62 ± 0.35# | 29 |
| HbA1c (%) | 9.51 ± 1.90 | 79 | 5.0 ± 0.39# | 21 |
| s-AGEs (A.U.)* | 67.85 (61.6; 76.4) | 70 | 58.2 (52.0; 65.5)# | 29 |
| AOPP (μmol/L)* | 80.5 (44.9; 139.9) | 59 | 58.5 (51.5; 66.9)# | 12 |
| LPO(nmol/mL)* | 119 (100.3; 156.3) | 48 | 99 (67; 106)# | 11 |
| TGF-β (ng/mL)* | 7.1 (3.6; 12.6) | 29 | 1.6 (0.8; 3.9)# | 9 |
The results are presented as mean ± SD in normal distribution and as median (1st quartile, 3rd quartile) in data with abnormal distribution.*
#significant difference in comparison with DM1 patients.